Overview
With a commitment to advancing healthcare through biotechnology, we are prepared to allocate capital in the range of $500,000 to $3,000,000. Our focus is on innovative projects that demonstrate clear potential for growth and impact. We are particularly interested in teams working on therapeutics, diagnostics, and breakthrough technologies that can address unmet medical needs. Successful candidates will have established proof of concept, a resilient business model, and a well-defined go-to-market strategy. We value passionate founders who show dedication and a strong understanding of their market dynamics.
Investor profile
Natalie Brooks is an experienced angel investor with a strong background in the biotech sector. She aims to support early to mid-stage startups looking to transform the healthcare landscape.
Requirements
Founders should present a solid business plan, demonstrate traction or validation of their technology, and possess a capable team committed to executing their vision.
Open investor offer
Open this investor offer to get access to investor contact details and continue communication with the investor.